Published in J Clin Invest on February 16, 2009
Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol (2011) 1.51
Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology (2009) 1.06
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol (2009) 1.01
Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. Eur J Neurol (2012) 0.95
Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS One (2013) 0.91
Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.90
Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J Clin Invest (2012) 0.87
Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. J Neurosci (2010) 0.85
Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation. J Neurosci (2015) 0.82
An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome. F1000 Biol Rep (2010) 0.80
Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin. Nat Rev Neurol (2015) 0.79
Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus. PLoS One (2015) 0.77
Guillain-Barré syndrome: a century of progress. Nat Rev Neurol (2016) 0.76
C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy. Acta Neuropathol Commun (2016) 0.75
Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies. PLoS One (2015) 0.75
Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis. Brain (2016) 0.75
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis. Sci Rep (2017) 0.75
Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination. Brain (2017) 0.75
Functional rafts in cell membranes. Nature (1997) 38.89
Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7.98
Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol (2001) 4.96
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature (2007) 3.75
Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci (1994) 3.19
Peripheral neuropathies and anti-glycolipid antibodies. Brain (2002) 3.04
Gangliosides are receptors for murine polyoma virus and SV40. EMBO J (2003) 2.99
Sweet spots in functional glycomics. Nat Chem Biol (2006) 2.50
SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc Natl Acad Sci U S A (2001) 2.48
The glycosynapse. Proc Natl Acad Sci U S A (2002) 2.46
Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med (2005) 2.31
A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med (1993) 2.29
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A (1996) 2.10
Organizational difference of cell surface "hematoside" in normal and virally transformed cells. Biochem Biophys Res Commun (1968) 2.04
The intracellular voyage of cholera toxin: going retro. Trends Biochem Sci (2003) 1.93
Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis (2001) 1.93
Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun (1994) 1.75
Gangliosides as components of lipid membrane domains. Glycobiology (2006) 1.71
Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem (1998) 1.69
Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry (1996) 1.65
Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain (1999) 1.55
Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A (2002) 1.54
Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun (2002) 1.48
Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol (2004) 1.45
Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest (1999) 1.42
b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem (2001) 1.38
Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci (2003) 1.29
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain (2001) 1.28
Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol (1999) 1.28
Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun (2002) 1.13
Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry (2006) 1.12
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain (2004) 1.10
Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A (2006) 1.08
Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol (1999) 1.07
Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci (2007) 1.07
Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci (2002) 1.05
Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol (1996) 1.02
Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci (2005) 1.02
The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim Biophys Acta (1996) 1.00
Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve (1993) 0.99
Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol (2005) 0.98
Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. J Immunol (1995) 0.97
Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol (2003) 0.97
Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes. Nat Clin Pract Neurol (2005) 0.92
Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Cancer Res (1992) 0.90
Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol Dis (2007) 0.89
Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci (2008) 0.89
Anti-GM1 antibodies as a model of the immune response to self-glycans. Biochim Biophys Acta (2007) 0.87
Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. Glycobiology (2006) 0.86
GD1b-specific antibody induces ataxia in Guillain-Barre syndrome. Neurology (2008) 0.84
Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy. Ann Neurol (1999) 0.83
Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J Neurochem (1996) 0.82
Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury. J Neuroimmunol (2008) 0.78
Cell membrane changes in brains manifesting senile plaques: an immunohistochemical study of GM1 membranous ganglioside. Brain Res (1990) 0.78
Topography of monosialoganglioside (GM1) in rat brain using monoclonal antibodies. Neurosci Lett (1989) 0.78
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet (2008) 5.08
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med (2003) 4.47
RNA polymerase II is required for RNAi-dependent heterochromatin assembly. Science (2005) 3.94
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron (2004) 3.28
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain (2008) 2.60
Complex formation of Plk1 and INCENP required for metaphase-anaphase transition. Nat Cell Biol (2005) 2.41
Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling. Mol Biol Cell (2007) 2.38
DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem Sci (2011) 2.28
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16
Palmitoylation-dependent protein sorting. J Cell Biol (2007) 2.14
Autophosphorylation of a newly identified site of Aurora-B is indispensable for cytokinesis. J Biol Chem (2004) 1.97
The intracellular dynamic of protein palmitoylation. J Cell Biol (2010) 1.95
Lipid rafts and the regulation of exocytosis. Traffic (2004) 1.91
Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain (2010) 1.90
Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat Rev Immunol (2006) 1.67
O-linked N-acetylglucosamine is present on the extracellular domain of notch receptors. J Biol Chem (2008) 1.65
The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat Med (2010) 1.63
Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol (2009) 1.58
Palmitoylation and membrane interactions of the neuroprotective chaperone cysteine-string protein. J Biol Chem (2008) 1.55
Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene (2003) 1.47
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem (2006) 1.44
IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol (2012) 1.43
O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions. Nat Commun (2011) 1.42
Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J Biol Chem (2005) 1.42
Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels. Proc Natl Acad Sci U S A (2008) 1.41
Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol (2009) 1.39
b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem (2001) 1.38
Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene (2002) 1.37
Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia (2007) 1.36
The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol (2003) 1.36
Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size. Proc Natl Acad Sci U S A (2006) 1.35
The SNARE proteins SNAP-25 and SNAP-23 display different affinities for lipid rafts in PC12 cells. Regulation by distinct cysteine-rich domains. J Biol Chem (2004) 1.35
Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur J Immunol (2003) 1.35
Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun (2006) 1.34
Structural, expression, and evolutionary analysis of mouse CIAS1. Gene (2004) 1.33
Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J Biomed Sci (2002) 1.29
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol (2009) 1.28
Syntaxin 6 regulates Glut4 trafficking in 3T3-L1 adipocytes. Mol Biol Cell (2003) 1.28
Munc18-1 prevents the formation of ectopic SNARE complexes in living cells. J Cell Sci (2007) 1.27
High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol (2010) 1.27
Palmitoylation of the SNAP25 protein family: specificity and regulation by DHHC palmitoyl transferases. J Biol Chem (2010) 1.26
Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C. J Biol Chem (2004) 1.23
Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol (2006) 1.23
Real-time monitoring of redox changes in the mammalian endoplasmic reticulum. J Cell Sci (2011) 1.21
O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1. Biochem Biophys Res Commun (2012) 1.21
Dual role of the cysteine-string domain in membrane binding and palmitoylation-dependent sorting of the molecular chaperone cysteine-string protein. Mol Biol Cell (2006) 1.20
Degradation of human Aurora-A protein kinase is mediated by hCdh1. FEBS Lett (2002) 1.20
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain (2012) 1.19
Ganglioside antibodies and neuropathies. Curr Opin Neurol (2008) 1.15
Analysis of the role of Aurora B on the chromosomal targeting of condensin I. Nucleic Acids Res (2007) 1.14
Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni. J Immunol (2012) 1.14
Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev (2013) 1.14
Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun (2002) 1.13
The hydrophobic cysteine-rich domain of SNAP25 couples with downstream residues to mediate membrane interactions and recognition by DHHC palmitoyl transferases. Mol Biol Cell (2009) 1.13
Immunologic glycosphingolipidomics and NKT cell development in mouse thymus. J Proteome Res (2009) 1.11
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain (2004) 1.10
Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol Cell Biol (2005) 1.10
Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci (2009) 1.09
Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve (2004) 1.09
Evidence for a role of the exocyst in insulin-stimulated Glut4 trafficking in 3T3-L1 adipocytes. J Biol Chem (2004) 1.08
t-SNARE protein conformations patterned by the lipid microenvironment. J Biol Chem (2010) 1.07
The fat controller: roles of palmitoylation in intracellular protein trafficking and targeting to membrane microdomains (Review). Mol Membr Biol (2008) 1.07
Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem (2003) 1.07
Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology (2009) 1.06
Plasma membrane targeting of exocytic SNARE proteins. Biochim Biophys Acta (2004) 1.06
Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci U S A (2005) 1.06
Dystrophin is required for appropriate retrograde control of neurotransmitter release at the Drosophila neuromuscular junction. J Neurosci (2006) 1.05
Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci (2002) 1.05
Palmitoylation of the synaptic vesicle fusion machinery. J Neurochem (2009) 1.05
Palmitoylation-induced aggregation of cysteine-string protein mutants that cause neuronal ceroid lipofuscinosis. J Biol Chem (2012) 1.05
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2003) 1.04
TRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle soreness. Pain (2008) 1.04
Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis. J Biol Chem (2005) 1.04
Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood (2011) 1.04
Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J Biol Chem (2004) 1.03
Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci (2005) 1.02
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A (2013) 1.02